tiprankstipranks
Unity Biotechnology Inc (UBX)
NASDAQ:UBX
US Market

Unity Biotechnology (UBX) Income Statement

Compare
755 Followers

Unity Biotechnology Income Statement

Last quarter (Q3 2024), Unity Biotechnology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Unity Biotechnology's net income was $-6.48M. See Unity Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 236.00K$ 4.78M$ 0.00$ 0.00
Gross Profit
$ -19.70M$ -1.94M$ 1.90M$ -3.45M$ -2.66M
Operating Expenses
$ 24.97M$ 57.81M$ 61.45M$ 91.33M$ 91.00M
Depreciation and Amortization
$ 1.18M$ 2.18M$ 2.88M$ 3.45M$ 2.66M
EBITDA
$ -37.28M$ -38.73M$ -54.67M$ -89.10M$ -89.65M
Operating Income
$ -44.67M$ -57.57M$ -56.66M$ -93.93M$ -89.65M
Other Income/Expenses
$ 4.81M$ 13.10M$ -4.06M$ 86.00K$ 7.47M
Pretax Income
$ -39.86M$ -59.93M$ -60.73M$ -93.84M$ -82.18M
Net Income
$ -39.86M$ -57.75M$ -60.04M$ -91.87M$ -74.87M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.70$ -6.08$ -10.76$ -18.06$ -17.16
Diluted EPS
$ -2.70$ -6.08$ -10.76$ -18.06$ -17.16
Weighted Average Shares Outstanding
14.77M 9.49M 5.58M 5.09M 4.36M
Weighted Average Shares Outstanding (Diluted)
14.77M 9.49M 5.58M 5.09M 4.36M
Currency in USD

Unity Biotechnology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis